Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0600
-0.0010 (-1.64%)
At close: Jan 9, 2026
Control Bionics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2018 - 2020 |
Operating Revenue | 6.14 | 5.35 | 5.64 | 4.5 | 3.97 | Upgrade |
Other Revenue | - | - | - | - | 0.12 | Upgrade |
| 6.14 | 5.35 | 5.64 | 4.5 | 4.09 | Upgrade | |
Revenue Growth (YoY) | 14.84% | -5.17% | 25.33% | 10.11% | 27.68% | Upgrade |
Cost of Revenue | 2.03 | 1.45 | 1.93 | 1.99 | 1.43 | Upgrade |
Gross Profit | 4.11 | 3.9 | 3.71 | 2.51 | 2.66 | Upgrade |
Selling, General & Admin | 8.64 | 7.7 | 8.45 | 8.12 | 5.44 | Upgrade |
Research & Development | 1.07 | 1.71 | 0.23 | 0.32 | 0.17 | Upgrade |
Other Operating Expenses | -0.86 | -0.99 | -0.45 | -0.35 | - | Upgrade |
Operating Expenses | 10.07 | 9.68 | 8.95 | 8.68 | 5.81 | Upgrade |
Operating Income | -5.96 | -5.78 | -5.24 | -6.18 | -3.15 | Upgrade |
Interest Expense | -0.11 | -0.06 | -0.02 | -0.01 | -0.07 | Upgrade |
Interest & Investment Income | 0.04 | 0.01 | 0.02 | 0 | 0 | Upgrade |
Earnings From Equity Investments | -0.06 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -0.01 | 0 | -0 | 0.03 | 0.1 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | -0.03 | -0.78 | Upgrade |
EBT Excluding Unusual Items | -6.1 | -5.82 | -5.24 | -6.19 | -3.89 | Upgrade |
Asset Writedown | -0.01 | -0.09 | - | - | - | Upgrade |
Other Unusual Items | - | - | -0.39 | 0.09 | 0.34 | Upgrade |
Pretax Income | -6.11 | -5.91 | -5.63 | -6.1 | -3.55 | Upgrade |
Net Income | -6.11 | -5.91 | -5.63 | -6.1 | -3.55 | Upgrade |
Net Income to Common | -6.11 | -5.91 | -5.63 | -6.1 | -3.55 | Upgrade |
Shares Outstanding (Basic) | 264 | 159 | 90 | 85 | 63 | Upgrade |
Shares Outstanding (Diluted) | 264 | 159 | 90 | 85 | 63 | Upgrade |
Shares Change (YoY) | 65.68% | 76.64% | 5.80% | 36.04% | 535.65% | Upgrade |
EPS (Basic) | -0.02 | -0.04 | -0.06 | -0.07 | -0.06 | Upgrade |
EPS (Diluted) | -0.02 | -0.04 | -0.06 | -0.07 | -0.06 | Upgrade |
Free Cash Flow | -4.57 | -5.31 | -4.96 | -7.03 | -4.04 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.06 | -0.08 | -0.06 | Upgrade |
Gross Margin | 66.94% | 72.82% | 65.78% | 55.68% | 65.03% | Upgrade |
Operating Margin | -96.95% | -108.02% | -92.78% | -137.19% | -77.01% | Upgrade |
Profit Margin | -99.41% | -110.52% | -99.80% | -135.53% | -86.85% | Upgrade |
Free Cash Flow Margin | -74.40% | -99.24% | -87.84% | -156.26% | -98.78% | Upgrade |
EBITDA | -5.14 | -5.06 | -4.87 | -5.76 | -3 | Upgrade |
EBITDA Margin | -83.64% | -94.50% | -86.31% | -127.93% | -73.28% | Upgrade |
D&A For EBITDA | 0.82 | 0.72 | 0.37 | 0.42 | 0.15 | Upgrade |
EBIT | -5.96 | -5.78 | -5.24 | -6.18 | -3.15 | Upgrade |
EBIT Margin | -96.95% | -108.02% | -92.78% | -137.19% | -77.01% | Upgrade |
Revenue as Reported | - | - | 6.11 | 4.94 | 4.43 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.